# Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening

> **NCT00607425** · — · TERMINATED · sponsor: **Scottsdale Healthcare** · enrollment: 40 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00607425
- **Lead sponsor:** Scottsdale Healthcare
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Change in isolation method
- **Last updated:** 2008-07-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607425, "Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00607425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*